The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

The activity of the epidermal growth factor receptor (EGFR) antibodies cetuximab and panitumumab in metastatic colorectal carcinoma (mCRC) is significantly limited by molecular mechanisms leading to intrinsic or acquired resistance. The S492R mutation of the EGFR, which is caused by either the 1476C...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Esposito, Claudia, Rachiglio, Anna Maria, La Porta, Maria Libera, Sacco, Alessandra, Roma, Cristin, Iannaccone, Alessia, Tatangelo, Fabiana, Forgione, Laura, Pasquale, Raffaella, Barbaro, Americo, Botti, Gerardo, Ciardiello, Fortunato, Normanno, Nicola
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Landes Bioscience 2013
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912037/
https://ncbi.nlm.nih.gov/pubmed/24025416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26340
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia